Neuronetics (FRA:NRC) Change In Other Working Capital : €-0.01 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Neuronetics Change In Other Working Capital?

Neuronetics's Change In Other Working Capital for the quarter that ended in Mar. 2024 was €0.07 Mil. It means Neuronetics's Other Working Capital increased by €0.07 Mil from Dec. 2023 to Mar. 2024 .

Neuronetics's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was €0.19 Mil. It means Neuronetics's Other Working Capital increased by €0.19 Mil from Dec. 2022 to Dec. 2023 .

Neuronetics Change In Other Working Capital Historical Data

The historical data trend for Neuronetics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuronetics Change In Other Working Capital Chart

Neuronetics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

Get a 7-Day Free Trial

-2.23

-1.11

0.48

-0.05

0.19

Neuronetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Other Working Capital	Get a 7-Day Free Trial															0.27	-0.08	0.07	-0.07	0.07

Neuronetics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.01 Mil.

Neuronetics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Neuronetics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuronetics (FRA:NRC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neuronetics Inc (FRA:NRC) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

STIM:USA NRC:Germany

Address

3222 Phoenixville Pike, Malvern, PA, USA, 19355

Website

https://www.neurostar.com

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.